Form 4: Columbia Financial Inc. Executive Klimowich Reports Stock Transactions
SEC Form 4 Filing
John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc., reports acquisition of common stock and holdings in derivative securities.
Summary
- On August 23, 2024, John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc. [CLBK], reported transactions involving the company's stock.
- Klimowich acquired 34.475 shares of common stock at a price of $17.85 through the Columbia Bank Stock Based Deferral Plan.
- Following the reported transaction, Klimowich directly owns 59,169 shares of common stock.
- Klimowich also indirectly owns shares through various plans including the Stock-Based Deferral Plan (6,301.8326 shares), 401(k) (17,130 shares), ESOP (6,451 shares), SERP (6,602 shares), SIM (4,214 shares), Stock Award II (15,159 shares), and Stock Award III (13,165 shares).
- Klimowich also holds options to buy 188,235 shares at $15.60 (fully vested), 12,030 shares at $15.94 (vesting starts May 1, 2024), and 8,850 shares at $16.49 (vesting starts March 6, 2025).
Sentiment
Score: 6
Explanation: The document is a neutral regulatory filing. The executive's stock acquisition could be viewed slightly positively, but overall, it's a standard disclosure.
Positives
- The acquisition of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements, but it does detail the vesting schedules for stock options and awards, providing insight into future equity compensation.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in the financial services industry. It provides transparency regarding the alignment of management's interests with those of shareholders.
Comparison to Industry Standards
- Equity compensation practices, including stock options and awards, are standard in the financial services industry to incentivize executives.
- Vesting schedules and performance-based criteria are common features of equity incentive plans, aligning executive compensation with company performance.
- Comparing the vesting schedules and option exercise prices to those of peer companies would provide a more detailed assessment of the competitiveness of Columbia Financial's compensation practices.
Stakeholder Impact
- Shareholders may view the executive's stock acquisition as a positive sign of confidence in the company.
- The filing provides transparency to stakeholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Date of grant for stock options exercisable until 07/23/2029. |
| 05/01/2024 | Commencement date for vesting of stock options granted at $15.94. |
| 08/23/2024 | Date of the reported stock transaction. |
| 08/27/2024 | Date of signature on the Form 4 filing. |
| 03/06/2025 | Commencement date for vesting of stock options granted at $16.49. |
| 05/01/2033 | Expiration date for stock options granted at $15.94. |
| 03/06/2034 | Expiration date for stock options granted at $16.49. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.